Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.02M | -23.77M | 8.74M | -11.62M | -24.44M |
| Total Depreciation and Amortization | 854.00K | 1.17M | 1.04M | 992.00K | 1.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.17M | 16.90M | -6.66M | 6.87M | 10.70M |
| Change in Net Operating Assets | -7.61M | -8.25M | 18.01M | 27.22M | 8.14M |
| Cash from Operations | 435.00K | -13.95M | 21.13M | 23.47M | -4.59M |
| Capital Expenditure | -298.00K | -3.58M | -828.00K | -331.00K | -430.00K |
| Sale of Property, Plant, and Equipment | -- | 44.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.00M | 0.00 | 0.00 | -350.00M | -- |
| Cash from Investing | 9.70M | -3.54M | -828.00K | -350.33M | -430.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 402.50M |
| Total Debt Repaid | -- | -52.06M | -- | -- | -- |
| Issuance of Common Stock | 2.55M | 550.00K | 198.00K | 298.00K | 5.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -1.12M | -12.24M |
| Cash from Financing | 2.55M | -51.51M | 198.00K | -818.00K | 396.01M |
| Foreign Exchange rate Adjustments | 8.43M | -13.03M | 12.29M | -159.00K | -800.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.11M | -82.04M | 32.78M | -327.84M | 390.20M |